Literature DB >> 25650190

Requiem for the grand round.

Maham Stanyon1, Shahid Anis Khan2.   

Abstract

The time-honoured tradition of Grand Round is firmly rooted in medical education, but has little evidence for its effectiveness or its impact on patient management. A mode of didactic teaching, Grand Round has lost its appeal in modern medical education with dwindling attendance at Grand Rounds worldwide. Once a platform for eminence-based medicine and a cross fertilisation of medical ideas, emphasis on sub-specialisation and clinical governance, combined with rota, trainee engagement and attendance failures has made Grand Round obsolete. To survive, Grand Round must have evidence for its effectiveness in medical education. It must be able to compete with other forms of teaching and adapt by using technology to reach trainees. Engaging the audience and encouraging participation needs to be woven into the fabric of the modern Grand Round, alongside learning clinical skills and developing clinical reasoning. Understanding the needs of today's trainees and their involvement in formulating the Grand Round programme is vital. Attendance at Grand Round is a recognised measure of its success and will be used in its evaluation. Questions still remain regarding the future of Grand Round. Its survival will depend upon its ability to change with time and reclaim its place as a credible tool to promote learning.
© 2015 Royal College of Physicians.

Entities:  

Keywords:  Grand Round; education

Mesh:

Year:  2015        PMID: 25650190      PMCID: PMC4954503          DOI: 10.7861/clinmedicine.15-1-10

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  2 in total

Review 1.  Experience Of Resident Presentations In Consultation-Liaison Psychiatry Grand Rounds: Increase Value For Clinical Education.

Authors:  Edwin S Meresh; David Daniels; Murali Rao; Aparna Sharma; Angelos Halaris; David Schilling
Journal:  Adv Med Educ Pract       Date:  2019-10-24

2.  Virtual grand rounds in COVID-19: A financial analysis.

Authors:  Megan Crossman; Dimitrios Papanagnou; Timothy Sullivan; Xiao Chi Zhang
Journal:  Acad Emerg Med       Date:  2021-03-23       Impact factor: 5.221

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.